Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1087 studies found for:    "Retinoschisis" OR "Retinal Degeneration" OR "X-linked juvenile retinoschisis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis
Condition: Retinoschisis
Intervention:
2 Recruiting Clinical Evaluation of Patients With X-linked Retinoschisis
Condition: X-linked Retinoschisis (XLRS)
Intervention: Drug: Dorzolamide 2% TID or brinzolamide 1% TID
3 Completed Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy
Conditions: Macular Retinoschisis;   Macular Detachment;   Normal Tension Glaucoma
Intervention: Procedure: Optical coherence tomography
4 Recruiting Molecular Genetics of Retinal Degenerations
Conditions: Retinal Degeneration;   Retinitis Pigmentosa
Intervention:
5 Recruiting Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
Condition: Gene Transfer
Intervention: Biological: RS1 AAV Vector
6 Recruiting Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration
Condition: Retinal Degenerations
Intervention: Drug: dorzolamide
7 Recruiting Color Vision as a Measure for Inherited Retinal Diseases
Conditions: Healthy Volunteer;   Retinal Disease;   Inherited Retinal Degeneration
Intervention:
8 Recruiting People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial
Conditions: Retinoschisis;   X-Linked
Intervention:
9 Completed Macular Detachment Associated With Intrachoroidal Cavitation
Conditions: Macular Detachment;   Macular Retinoschisis;   Intrachoroidal Cavitation
Intervention: Other: Vitrectomy
10 Active, not recruiting Saffron Supplementation in Stargardt's Disease
Conditions: Retinal Degeneration;   Genetic Disease;   Single-Gene Defects;   Macular Dystrophy
Interventions: Dietary Supplement: Saffron supplementation;   Other: placebo
11 Unknown  Macular Tractional Retinoschisis in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention:
12 Active, not recruiting Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis
Condition: Retinal Degeneration
Intervention: Biological: tgAAG76 (rAAV 2/2.hRPE65p.hRPE65)
13 Recruiting Cell Collection to Study Eye Diseases
Conditions: Retinal Disease;   AMD;   Retinal Degeneration
Intervention:
14 Active, not recruiting Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
Conditions: Macular Degeneration;   Age-related Maculopathies;   Age-related Maculopathy;   Maculopathies,Age-related;   Maculopathy,Age-related;   Retinal Degeneration;   Retinal Neovascularization;   Eye Diseases
Interventions: Biological: rAAV.sFlt-1;   Other: Control (ranibizumab alone)
15 Recruiting Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinitis Pigmentosa;   Retinal Degeneration
Intervention: Device: Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye
16 Enrolling by invitation Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration
Conditions: Retinal Degeneration;   Primary Open-Angle Glaucoma
Interventions: Other: Subtenon administration of autologous ADRC;   Procedure: Liposuction;   Device: ADRC isolation
17 Recruiting Natural History of Eye Diseases Related to ABCA4 Mutations
Conditions: Retinal Degeneration;   ABCA4-Related Retinopathies
Intervention:
18 Completed Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
Conditions: Healthy;   Muscular Dystrophy;   Retinal Degeneration;   Skin Diseases;   Virus Diseases
Intervention:
19 Recruiting Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
Conditions: Inherited Ophthalmic Diseases;   Inherited Retinal Degeneration
Intervention: Drug: Interferon gamma-1b
20 Active, not recruiting Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Conditions: Macular Degeneration;   Age-Related Maculopathies;   Age-Related Maculopathy;   Maculopathies, Age-Related;   Maculopathy, Age-Related;   Retinal Degeneration;   Retinal Neovascularization;   Gene Therapy;   Therapy, Gene;   Eye Diseases
Intervention: Biological: AAV2-sFLT01

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years